BTL Industries Ltd.

Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway

Role: lead

EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress

Role: lead

EEG Changes After rTMS Stimulation

Role: lead

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

Role: lead

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women

Role: lead

EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings

Role: lead

EXOMIND (BTL-699) for the Reduction of Food Cravings

Role: lead

EXOMIND (BTL-995) for the Reduction of Binge-eating

Role: lead

EXOMIND (BTL-995) for Reduction of Binge-eating

Role: lead

Device for Improving Skin Quality and Texture on the Face and Neck

Role: lead

EXOMIND (BTL-699-2) for Improvement of Mental Well-being

Role: lead

Non-invasive Rejuvenation of the Periorbital Area and Lower Eyelid

Role: lead

HIFEM for Musculoskeletal System Improvement

Role: lead

Combination of BTL-785F and HPM-6000UF Devices for Women's Intimate Wellness

Role: lead

Histological Evaluation of BTL-785F Device's Effect on Submental Subcutaneous Adipose Tissue

Role: lead

BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement

Role: lead

BTL-785F Device for Non-invasive Treatment of Wrinkles and Improvement of the Face Appearance

Role: lead

HIFEM and Radiofrequency for Muscular System Function Improvement

Role: lead

Safety and Efficacy of the BTL-754 Device for Laser Skin Resurfacing Treatment of the Face

Role: lead

Evaluation of the BTL-785F Device for Submental Fat Reduction and Neck Rejuvenation

Role: lead